Associate Professor of Neurology Yale University, Medical Director of Electroencephalography (EEG) Yale-New Haven Hospital, Program Director of Clinical Neurophysiology (ACGME) fellowship at Yale-New hven Hospital ,
Neurology
Dr. Ognen A. Petroff, MD
|
|
Give Review
Ognen A. Petroff, MD practices Neurology. He graduated from Yale University School of Medicine. Yale University School of Medicine is a top medical college. Yale University School of Medicine is ranked 7/57 in Research/PrimaryCare. Doctor Ognen A. Petroff, MD is a published MD as well. He has 101 publications published. The latest was: Vigabatrin increases human brain homocarnosine and improves seizure control.
Publications
- A comparison of the power spectral density of scalp EEG and subjacent electrocorticograms.
- Brief Potentially Ictal Rhythmic Discharges in Critically Ill Adults.
- Similarity of Lateralized Rhythmic Delta Activity to Periodic Lateralized Epileptiform Discharges in Critically Ill Patients.
- 7T MR spectroscopic imaging in the localization of surgical Epilepsy.
- Glutamate and astrocytes--key players in human mesial temporal lobe Epilepsy?
- Blockade of GABA synthesis only affects neural excitability under activated conditions in rat hippocampal slices.
- Neurometabolism in human Epilepsy.
- Brain homocarnosine and seizure control of patients taking gabapentin or topiramate.
- Family psychopathology and magnitude of reductions in occipital cortex GABA levels in panic disorder.
- Acute effects of gabapentin and pregabalin on rat foreBrain cellular GABA, glutamate, and glutamine concentrations.
- N-acetyl-aspartate, total creatine, and myo-inositol in the epileptogenic human hippocampus.
- GABA and glutamate in the human Brain.
- Neuronal and glial metabolite content of the epileptogenic human hippocampus.
- Glutamate-glutamine cycling in the epileptic human hippocampus.
- Gabapentin and vigabatrin increase GABA in the human neocortical slice.
- GABA and the ornithine delta-aminotransferase gene in vigabatrin-associated visual field defects.
- Topiramate rapidly raises Brain GABA in epilepsy patients.
- Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy.
- Homocarnosine and seizure control in juvenile myoclonic Epilepsy and complex partial seizures.
- Proton MRS: GABA and glutamate.
- A comparison of four new antiepileptic medications.
- Effects of gabapentin on Brain GABA, homocarnosine, and pyrrolidinone in epilepsy patients.
- Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy.
- Effects of vigabatrin on the GABAergic System as determined by [123I]iomazenil SPECT and GABA MRS.
- New NMR measurements in epilepsy. Measuring Brain GABA in patients with complex partial seizures.
- Acute effects of vigabatrin on Brain GABA and homocarnosine in patients with complex partial seizures.
- Determination of the rate of the glutamate/glutamine cycle in the human Brain by in vivo 13C NMR.
- Preliminary evidence of low cortical GABA levels in localized 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients.
- Localized 1H NMR measurements of 2-pyrrolidinone in human Brain in vivo.
- Effects of valproate and other antiepileptic drugs on Brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures.
- Topiramate increases Brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy.
- Vigabatrin increases human Brain homocarnosine and improves seizure control.
- Measuring human Brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin.
- Novel methods for studying new antiepileptic drug pharmacology.
- Homocarnosine and the measurement of neuronal pH in patients with Epilepsy.
- Low Brain GABA level is associated with poor seizure control.
- Reversible, reproducible reduction of Brain water apparent diffusion coefficient by cortical electroshocks.
- Human Brain GABA levels rise rapidly after initiation of vigabatrin therapy.
- Human Brain gamma-aminobutyric acid levels and seizure control following initiation of vigabatrin therapy.
- The rate of turnover of cortical GABA from [1-13C]glucose is reduced in rats treated with the GABA-transaminase inhibitor vigabatrin (gamma-vinyl GABA).
- Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human Brain.
- Diffusion-weighted NMR imaging changes caused by electrical activation of the Brain.
- Human Brain GABA levels rise after initiation of vigabatrin therapy but fail to rise further with increasing dose.
- Effects of osmotically driven cell volume changes on diffusion-weighted imaging of the rat optic nerve.
- The effect of gabapentin on Brain gamma-aminobutyric acid in patients with epilepsy.
- Localized 1H NMR measurements of gamma-aminobutyric acid in human Brain in vivo.
- Proton magnetic resonance spectroscopy in Creutzfeldt-Jakob Disease.
- Changes in water diffusion and relaxation properties of rat cerebrum during status epilepticus.
- Idiopathic granulomatous angiitis of the central Nervous system. Diagnostic challenges.
- Early temporal variation of Cerebral metabolites after human stroke. A proton magnetic resonance spectroscopy study.
- Vigabatrin: effects on human Brain GABA levels by nuclear magnetic resonance spectroscopy.
- BOLD MRI monitoring of changes in Cerebral perfusion induced by acetazolamide and hypercarbia in the rat.
- Analysis of macromolecule resonances in 1H NMR spectra of human Brain.
- Metabolic assessment of a neuron-enriched fraction of rat cerebrum using high-resolution 1H and 13C NMR spectroscopy.
- In vivo measurement of phenylalanine in human Brain by proton nuclear magnetic resonance spectroscopy.
- Barbiturate-reversible reduction of water diffusion coefficient in flurothyl-induced status epilepticus in rats.
- Initial observations on effect of vigabatrin on in vivo 1H spectroscopic measurements of gamma-aminobutyric acid, glutamate, and glutamine in human Brain.
- Vigabatrin: effect on Brain GABA levels measured by nuclear magnetic resonance spectroscopy.
- Detection of Cerebral lactate in vivo during hypoxemia by 1H NMR at relatively low field strengths (1.9 T).
- High-resolution 1H nuclear magnetic resonance study of Cerebral hypoxia in vivo.
- Cerebral metabolic studies in vivo by 31P NMR.
- In vivo phosphorus nuclear magnetic resonance spectroscopy in status epilepticus.
- Cerebral pH by NMR.
- Cerebral intracellular pH by 31P nuclear magnetic resonance spectroscopy.
- Combined 1H and 31P nuclear magnetic resonance spectroscopic studies of bicuculline-induced seizures in vivo.
- High-resolution proton magnetic resonance analysis of human cerebroSpinal fluid.
- Proton magnetic resonance spectroscopy of leech muscle and Nervous system.
- 31P magnetization transfer studies of creatine kinase kinetics in living rabbit Brain.
- Cerebral lactate elevation by electroshock: a 1H magnetic resonance study.
- In vivo 31P and in vitro 1H nuclear magnetic resonance study of hypoglycemia during neonatal seizure.
- Proton magnetic resonance spectroscopic studies of agonal carbohydrate metabolism in rabbit Brain.
- High-resolution proton magnetic resonance spectroscopy of rabbit Brain: regional metabolite levels and postmortem changes.
- 1H nuclear magnetic resonance spectroscopy study of neonatal hypoglycemia.
- Biological 1H NMR spectroscopy.
- Cerebral metabolism in hyper- and hypocarbia: 31P and 1H nuclear magnetic resonance studies.
- The effect of diazepam on neonatal seizure: in vivo 31P and 1H NMR study.
- Detection of metabolites in rabbit Brain by 13C NMR spectroscopy following administration of [1-13C]glucose.
- 1H-Observe/13C-decouple spectroscopic measurements of lactate and glutamate in the rat Brain in vivo.
- Effect of hypoglycemic encephalopathy upon amino acids, high-energy phosphates, and pHi in the rat Brain in vivo: detection by sequential 1H and 31P NMR spectroscopy.
- High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for Epilepsy.
- Thromboxane synthesis inhibitor in a beagle pup model of perinatal asphyxia.
- Beagle puppy model of perinatal asphyxia: blockade of excitatory neurotransmitters.
- In vivo measurements of ethanol concentration in rabbit Brain by 1H magnetic resonance spectroscopy.
- Measurement of ethanol in the human Brain using NMR spectroscopy.
- Neonatal seizure: magnetic resonance spectroscopic findings.
- Proton NMR observation of phenylalanine and an aromatic metabolite in the rabbit Brain in vivo.
- Neonatal excitotoxic Brain injury. Physiologic, metabolic, and pathologic findings.
- Direct carbon versus proton heteronuclear editing of 2-13C ethanol in rabbit Brain in vivo: a sensitivity comparison.
- Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation.
- Brain energy state and lactate metabolism during status epilepticus in the neonatal dog: in vivo 31P and 1H nuclear magnetic resonance study.
- Preferential utilization of lactate in neonatal dog Brain: in vivo and in vitro proton NMR study.
- Localized proton NMR observation of [3-13C]lactate in Stroke after [1-13C]glucose infusion.
- Effects of glutamate, quisqualate, and N-methyl-D-aspartate in neonatal Brain.
- Metabolism of [1-13C]glucose in a synaptosomally enriched fraction of rat cerebrum studied by 1H/13C magnetic resonance spectroscopy.
- Spectroscopic imaging of Stroke in humans: histopathology correlates of spectral changes.
- Hyperglycemia and the rate of lactic acid accumulation during Cerebral ischemia in developing animals: in vivo proton MRS study.
- Quantitative analysis of rat synaptosomes and cerebrum using high-resolution 1H magnetic resonance spectroscopy.
- Proton magnetic resonance spectroscopy of Cerebral lactate and other metabolites in stroke patients.
- 1H-[13C] NMR measurements of [4-13C]glutamate turnover in human Brain.
- Cerebral lactate turnover after electroshock: in vivo measurements by 1H/13C magnetic resonance spectroscopy.
Schools
Johns Hopkins University School of Medicine
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Bell's Palsy
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Clinical Neurophysiology
- Neurology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amalgamated Clothing & Textile Workers Union WC
- Pathway X Ind PPO Direct Access CT
- Blue Card PPO
- Commercial Insurance Company
- Connecticare HMO
- Connecticare POS
- CoreSource
- Health Insurance Plan of Greater New York (HIP) PPO
- Golden Rule
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Freedom Plan
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- United Healthcare
Education
-
Yale University School of Medicine -
Yale-New Haven Hospital -
Pennsylvania Hospital - University of Pennsylvania Health System -
Johns Hopkins University School of Medicine
Hospital
-
Yale-New Haven Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1427030162 |
| Last Name Of The Provider | PETROFF |
| First Name Of The Provider | OGNEN |
| View All |
Similar Doctors
|
|
Dr. Laura R. Ment, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joachim M. Baehring, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert B. Duckrow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Huned S. Patwa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen G. Waxman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence J. Hirsch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeremy J. Moeller, MD |
|
|
Dr. Adithya Sivaraju, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Justin R. Marcus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Imran H. Quraishi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anupama Alareddy, MD |
|
|
Dr. Irene H. Yang, MD |
|
|
Dr. P Christopher Gottschalk, MD |
|
|
Robert G. Kowalski
This Doctor is OpenDoctor Recommended.
|